Doing Business with the National Institutes of Health (NIH): Opportunities for industry
Licensing through the NIH, which runs one of the largest technology transfer efforts in the US biomedical field, is but one way to work with NIH. Collaborating with NIH can also provide access to drug screening services, databases, clinical trial testing networks, repositories of research reagents and natural products, etc, not to mention access to thousands of potential top notch collaborators and deep-pocketed customers. In 2007, the NIH spent approximately $25B to conduct research in the form of grants and contracts.
DATE | TIME | LOCATION
April 7, 20084:00PM - 6:00PM
MaRS Centre, CR3
101 College St.
Toronto, ON
DOWNLOADS AND RESOURCES
EVENT PARTNERS
 |
 |
ABOUT THE SPEAKERS
Claire T. Driscoll, Director, Technology Transfer OfficeA 17-year veteran of the National Institutes of Health, Claire Driscoll has served as the Director of the National Human Genome Research Institute (NHGRI)’s Technology Transfer Office (Bethesda, MD). Since 2002, Ms. Driscoll is responsible for the overall oversight of the Institute’s intramural patent and licensing portfolio and she advises staff on technology transfer policy and related matters. From 1999 through 2002, Ms. Driscoll was the Associate Director of NHGRI’s Technology Transfer Office.
Prior to joining NHGRI, Claire spent almost five years as a Senior Technology Development Manager with the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) (1994-1999). From 1990-1994, she was a biologist in a National Institute of Child Health and Development (NICHD) laboratory at NIH. Her education includes BSc and MSc degrees in Biology from the University of Notre Dame (Notre Dame, Indiana). Claire is the former Chair of the Technology Council of Maryland’s bioalliance program planning committee and the NIH technology development coordinators group. She is also an active member of both AUTM’s annual meeting program and LES’ life sciences committees.
Mukul Ranjan, Ph.D. , Branch Chief, Intramural Agreements Branch, Office of Technology Development , National Institute of Allergy and Infectious Diseases
Dr. Ranjan, is Branch Manager at NIAID’s Office of Technology Development and represents NIIAD in collaborations between the public, private academic and non-profit sectors.
Dr. Ranjan has extensive knowledge of intellectual property and U.S. patent laws, issues and procedures, and is a member of the US Patent Bar. He has worked at the U.S. Patent and Trademark Office (PTO) as a Biotechnology Patent Examiner dealing with receptors and cytokines. Before joining the PTO, Dr. Ranjan was a research scientist at NIH studying gene regulation during early embryonic development and examining gene expression during cell differentiation in the context of multiple sclerosis and has published in numerous scientific journals.
Dr. Ranjan has a special interest in alleviating the global disease burden due to infectious disease and is keenly interested in international collaborations and development issues. He has also lectured on patent law to students in the Biotechnology Law and Policy Foundation for the Advancement of Education on the Sciences (FAES). Dr. Ranjan has an MSc from the University of New Delhi and a PhD from the University of Notre Dame.
UPCOMING EVENTS
PAST EVENTS
- October 9, 2008
Best Practices: Is Your Business Model Creative? - June 3, 2008
MaRS Best Practices Series - Good Laboratory Practices - May 13, 2008
MaRS Best Practices Series - From bench top to IND - April 24, 2008
MaRS Best Practices Series - IP Strategies for Medical Devices - April 7, 2008
MaRS Best Practices Series - Doing Business with the National Institutes of Health (NIH): Opportunities for industry - March 29, 2008
MaRS Best Practices Series - How to Draft a Patent Application - March 20, 2008
MaRS Best Practices Series - IP Strategies for Therapeutics - February 28, 2008
MaRS Best Practices Series - IP Strategies for Diagnostics - February 23, 2008
MaRS Best Practices Series - How to Draft a Patent Application - December 12, 2007
MaRS Best Practices Series - Focus on CNS Pharma deals: How to pull in the money - May 23, 2007
MaRS Best Practices Series - Pre-Clinical development workshop - MaRS Best Practices Series - Asymmetric Communications: Building Momentum through Non-Traditional Marketing
- April 11, 2007
MaRS Best Practices Series - Intellectual Property and Valuation of Emerging Medical Therapeutics - November 21, 2006
MaRS Best Practices Series - Business, Science, Technology and You: Financing R&D through Canada’s SR&ED Program - November 9, 2006
MaRS Best Practices Series - Introduction to Systems Biology - September 14, 2006
MaRS Best Practices Series - From Bench to Headline: Translating science for the media - September 8, 2006
MaRS Besst Practices Series - The Power of Pictonics: Using visualizations to tell your technology story - July 12, 2006
MaRS Best Practices Series - Why commercializing a technology is really, really hard to do - May 17, 2006
MaRS Best Practices Series - So what? Who cares? Why you? - April 5, 2006
MaRS Best Practices Series - The move toward drug development - February 11, 2006
MaRS Best Practices Series - How To Draft a Patent Application - February 9, 2006
MaRS Best Practices Series - New Technologies for Accelerating Drug Development
